TEST BANK gb
Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 6th Edition
gb gb gb gb gb gb gb
Author: Teri Moser Woo and Wendy L. Wright
gb gb gb gb gb gb gb
, TABLE OF CONTENTgb gb
Chapter 1. The Role of the Advanced Practice Nurse as Prescriber ..................................................................... 4
gb gb gb gb gb gb gb gb gb gb
Chapter 2. Review of Basic Principles of Pharmacology...................................................................................... 5
gb gb gb gb gb gb gb
Chapter 3. Rational Drug Selection..................................................................................................................... 11
gb gb gb gb
Chapter 4. Legal and Professional Issues in Prescribing ..................................................................................... 14
gb gb gb gb gb gb gb
Chapter 5. Adverse Drug Reactions .................................................................................................................... 16
gb gb gb gb
Chapter 6. An Introduction to Pharmacogenomics ............................................................................................. 19
gb gb gb gb gb
Chapter 7. Nutrition and Nutraceuticals .............................................................................................................. 22
gb gb gb gb
Chapter 8. Herbal Therapies ................................................................................................................................ 28
gb gb gb
Chapter 9. Cannabis ............................................................................................................................................ 31
gb gb
Chapter 10. Pharmacoeconomics ........................................................................................................................ 35
gb gb
Chapter 11. Drugs Affecting the Autonomic Nervous System ........................................................................... 38
gb gb gb gb gb gb gb
Chapter 12. Drugs Affecting the Central Nervous System ................................................................................. 45
gb gb gb gb gb gb gb
Chapter 13. Drugs Affecting the Cardiovascular and Renal Systems ................................................................. 53
gb gb gb gb gb gb gb gb
Chapter 14. Drugs Affecting the Respiratory System ......................................................................................... 61
gb gb gb gb gb gb
Chapter 15. Drugs Affecting the Hematological System .................................................................................... 65
gb gb gb gb gb gb
Chapter 16. Drugs Affecting the Immune System: Vaccines and Immunoglobulins .......................................... 69
gb gb gb gb gb gb gb gb gb
Chapter 17. Drugs Affecting the Immune System: Immunomodulators ............................................................. 75
gb gb gb gb gb gb gb
Chapter 18. Drugs Affecting the Gastrointestinal System .................................................................................. 77
gb gb gb gb gb gb
Chapter 19. Drugs Affecting the Endocrine System: Pancreatic Hormones and Antidiabetic Drugs ................... 80
gb gb gb gb gb gb gb gb gb gb gb
Chapter 20. Drugs Affecting the Endocrine System: Pituitary, Thyroid, and Adrenal Drugs ............................ 83
gb gb gb gb gb gb gb gb gb gb gb
Chapter 21. Drugs Affecting the Reproductive System ...................................................................................... 86
gb gb gb gb gb gb
Chapter 22. Drugs Affecting the Bones and Joints ............................................................................................. 92
gb gb gb gb gb gb gb
Chapter 23. Drugs Affecting the Integumentary System .................................................................................... 96
gb gb gb gb gb gb
Chapter 24. Drugs Used to Treat Bacterial Infections ...................................................................................... 101
gb gb gb gb gb gb gb
Chapter 25. Drugs Used to Treat Viral, Fungal, and Protozoal Infections ....................................................... 105
gb gb gb gb gb gb gb gb gb gb
Chapter 26. Drugs Used to Treat Inflammatory Processes ............................................................................... 108
gb gb gb gb gb gb gb
Chapter 27. Drugs Used to Treat Eye and Ear Disorders .................................................................................. 111
gb gb gb gb gb gb gb gb gb
Chapter 28. Anemia .......................................................................................................................................... 113
gb gb
Chapter 29. Anxiety and Depression................................................................................................................. 116
gb gb gb gb
Chapter 30. Attention Deficit-Hyperactivity Disorder ...................................................................................... 120
gb gb gb gb
Chapter 31. Asthma and Allergy ....................................................................................................................... 122
gb gb gb gb
Chapter 32. Chronic Obstructive Pulmonary Disease ....................................................................................... 125
gb gb gb gb gb
Chapter 33. Contraception ................................................................................................................................. 127
gb gb
Chapter 34. COVID-19: Acute and Chronic ..................................................................................................... 130
gb gb gb gb gb
Chapter 35. Dermatological Conditions ............................................................................................................ 134
gb gb gb
Chapter 36. Diabetes Management ................................................................................................................... 138
gb gb gb
Chapter 37. Gastroesophageal Reflux and Peptic Ulcer Disease ...................................................................... 146
gb gb gb gb gb gb gb
Chapter 38. Headaches ...................................................................................................................................... 149
gb gb
Chapter 39. Heart Failure .................................................................................................................................. 153
gb gb gb
Chapter 40. HIV Disease and Acquired Immunodeficiency Syndrome ............................................................ 158
gb gb gb gb gb gb gb
Chapter 41. Menopausal Hormone Therapy ..................................................................................................... 161
gb gb gb gb
,Chapter 42. Hyperlipidemia .............................................................................................................................. 164
gb gb
Chapter 43. Hypertension .................................................................................................................................. 169
gb gb
Chapter 44. Hyperthyroidism and Hypothyroidism .......................................................................................... 174
gb gb gb gb
Chapter 45. Obesity ........................................................................................................................................... 177
gb gb
Chapter 46. Pain Management: Acute and Chronic Pain .................................................................................. 181
gb gb gb gb gb gb gb
Chapter 47. Pneumonia ..................................................................................................................................... 185
gb gb
Chapter 48. Sexually Transmitted Diseases and Vaginitis ................................................................................ 187
gb gb gb gb gb gb
Chapter 49. Substance Use Disorders ............................................................................................................... 190
gb gb gb gb
Chapter 50. Tuberculosis ................................................................................................................................... 195
gb gb
Chapter 51. Upper Respiratory Tract Infection, Pharyngitis, Sinusitis, Otitis Media, and Otitis Externa .......... 197
gb gb gb gb gb gb gb gb gb gb gb gb
Chapter 52. Urinary Tract Infections ................................................................................................................ 200
gb gb gb gb
Chapter 53. Women as Patients......................................................................................................................... 203
gb gb gb gb
Chapter 54. Men as Patients .............................................................................................................................. 207
gb gb gb gb
Chapter 55. Pediatric Patients ........................................................................................................................... 209
gb gb gb
Chapter 57. Geriatric Patients ........................................................................................................................... 213
gb gb gb
, Woo 1
Pharmacotherapeutics for APN Prescribers, 6e gb gb gb gb Ch01
Chapter 1. The Role of the Advanced Practice Nurse as Prescriber
gb gb gb gb gb gb gb gb gb gb
MULTIPLE CHOICE gb
1. Nurse practitioner prescriptive authority is regulated by:
gb gb gb gb gb gb
A. The National Council of State Boards of Nursing
gb gb gb gb gb gb gb
B. The U.S. Drug Enforcement Administration
gb gb gb gb
C. The State Board of Nursing for each state
gb gb gb gb gb gb gb
D. The State Board of Pharmacy
gb gb gb gb
ANS: C g b PTS: g b g b 1
2. The benefits to the patient of having an advanced practice registered nurse (APRN) prescriber i
gb gb gb gb gb gb gb gb gb gb gb gb gb gb
nclude:
A. Nurses know more about pharmacology than other prescribers because they take it
gb gb gb gb gb gb gb gb gb gb gb gb
both in their basic nursing program and in their APRN program.
gb gb gb gb gb gb gb gb gb gb
B. Nurses care for the patient from a holistic approach and include the patient in
gb gb gb gb gb gb gb gb gb gb gb gb gb gb
decision-making regarding their care. gb gb gb
C. APRNs are less likely to prescribe narcotics and other controlled substances.
gb gb gb gb gb gb gb gb gb gb
D. APRNs are able to prescribe independently in all states, whereas a physician’s
gb gb gb gb gb gb gb gb gb gb gb gb
assistant needs to have a physician supervising their practice.
gb gb gb gb gb gb gb gb
ANS: B g b PTS: g b g b 1
3. Clinical judgment in prescribing includes:
gb gb gb gb
A. Factoring in the cost to the patient of the medication prescribed
gb gb gb gb gb gb gb gb gb gb
B. Always prescribing the newest medication available for the disease process
gb gb gb gb gb gb gb gb gb
C. Handing out drug samples to poor patients gb gb gb gb gb gb
D. Prescribing all generic medications to cut costs gb gb gb gb gb gb
ANS: A g b PTS: g b g b 1
4. The process for choosing an effective drug for a disorder includes:
gb gb gb gb gb gb gb gb gb gb
A. Asking the patient what drug they think would work best for them
gb gb gb gb gb gb gb gb gb gb gb
B. Consulting nationally recognized guidelines for disease management
gb gb gb gb gb gb
C. Prescribing medications that are available as samples before writing a prescription
gb gb gb gb gb gb gb gb gb gb
D. Following U.S. Drug Enforcement Administration guidelines for prescribing
gb gb gb gb gb gb gb
ANS: B g b PTS: g b g b 1
5. Nonintentional nonadherence of drug therapy may occur due to: gb gb gb gb gb gb gb gb
A. Belief that medication does not work
gb gb gb gb gb
B. Adverse drug reactions gb gb
C. Chronic conditions that require daily therapygb gb gb gb gb
D. Forgetfulness or distraction gb gb
ANS: D g b PTS: g b g b 1
Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 6th Edition
gb gb gb gb gb gb gb
Author: Teri Moser Woo and Wendy L. Wright
gb gb gb gb gb gb gb
, TABLE OF CONTENTgb gb
Chapter 1. The Role of the Advanced Practice Nurse as Prescriber ..................................................................... 4
gb gb gb gb gb gb gb gb gb gb
Chapter 2. Review of Basic Principles of Pharmacology...................................................................................... 5
gb gb gb gb gb gb gb
Chapter 3. Rational Drug Selection..................................................................................................................... 11
gb gb gb gb
Chapter 4. Legal and Professional Issues in Prescribing ..................................................................................... 14
gb gb gb gb gb gb gb
Chapter 5. Adverse Drug Reactions .................................................................................................................... 16
gb gb gb gb
Chapter 6. An Introduction to Pharmacogenomics ............................................................................................. 19
gb gb gb gb gb
Chapter 7. Nutrition and Nutraceuticals .............................................................................................................. 22
gb gb gb gb
Chapter 8. Herbal Therapies ................................................................................................................................ 28
gb gb gb
Chapter 9. Cannabis ............................................................................................................................................ 31
gb gb
Chapter 10. Pharmacoeconomics ........................................................................................................................ 35
gb gb
Chapter 11. Drugs Affecting the Autonomic Nervous System ........................................................................... 38
gb gb gb gb gb gb gb
Chapter 12. Drugs Affecting the Central Nervous System ................................................................................. 45
gb gb gb gb gb gb gb
Chapter 13. Drugs Affecting the Cardiovascular and Renal Systems ................................................................. 53
gb gb gb gb gb gb gb gb
Chapter 14. Drugs Affecting the Respiratory System ......................................................................................... 61
gb gb gb gb gb gb
Chapter 15. Drugs Affecting the Hematological System .................................................................................... 65
gb gb gb gb gb gb
Chapter 16. Drugs Affecting the Immune System: Vaccines and Immunoglobulins .......................................... 69
gb gb gb gb gb gb gb gb gb
Chapter 17. Drugs Affecting the Immune System: Immunomodulators ............................................................. 75
gb gb gb gb gb gb gb
Chapter 18. Drugs Affecting the Gastrointestinal System .................................................................................. 77
gb gb gb gb gb gb
Chapter 19. Drugs Affecting the Endocrine System: Pancreatic Hormones and Antidiabetic Drugs ................... 80
gb gb gb gb gb gb gb gb gb gb gb
Chapter 20. Drugs Affecting the Endocrine System: Pituitary, Thyroid, and Adrenal Drugs ............................ 83
gb gb gb gb gb gb gb gb gb gb gb
Chapter 21. Drugs Affecting the Reproductive System ...................................................................................... 86
gb gb gb gb gb gb
Chapter 22. Drugs Affecting the Bones and Joints ............................................................................................. 92
gb gb gb gb gb gb gb
Chapter 23. Drugs Affecting the Integumentary System .................................................................................... 96
gb gb gb gb gb gb
Chapter 24. Drugs Used to Treat Bacterial Infections ...................................................................................... 101
gb gb gb gb gb gb gb
Chapter 25. Drugs Used to Treat Viral, Fungal, and Protozoal Infections ....................................................... 105
gb gb gb gb gb gb gb gb gb gb
Chapter 26. Drugs Used to Treat Inflammatory Processes ............................................................................... 108
gb gb gb gb gb gb gb
Chapter 27. Drugs Used to Treat Eye and Ear Disorders .................................................................................. 111
gb gb gb gb gb gb gb gb gb
Chapter 28. Anemia .......................................................................................................................................... 113
gb gb
Chapter 29. Anxiety and Depression................................................................................................................. 116
gb gb gb gb
Chapter 30. Attention Deficit-Hyperactivity Disorder ...................................................................................... 120
gb gb gb gb
Chapter 31. Asthma and Allergy ....................................................................................................................... 122
gb gb gb gb
Chapter 32. Chronic Obstructive Pulmonary Disease ....................................................................................... 125
gb gb gb gb gb
Chapter 33. Contraception ................................................................................................................................. 127
gb gb
Chapter 34. COVID-19: Acute and Chronic ..................................................................................................... 130
gb gb gb gb gb
Chapter 35. Dermatological Conditions ............................................................................................................ 134
gb gb gb
Chapter 36. Diabetes Management ................................................................................................................... 138
gb gb gb
Chapter 37. Gastroesophageal Reflux and Peptic Ulcer Disease ...................................................................... 146
gb gb gb gb gb gb gb
Chapter 38. Headaches ...................................................................................................................................... 149
gb gb
Chapter 39. Heart Failure .................................................................................................................................. 153
gb gb gb
Chapter 40. HIV Disease and Acquired Immunodeficiency Syndrome ............................................................ 158
gb gb gb gb gb gb gb
Chapter 41. Menopausal Hormone Therapy ..................................................................................................... 161
gb gb gb gb
,Chapter 42. Hyperlipidemia .............................................................................................................................. 164
gb gb
Chapter 43. Hypertension .................................................................................................................................. 169
gb gb
Chapter 44. Hyperthyroidism and Hypothyroidism .......................................................................................... 174
gb gb gb gb
Chapter 45. Obesity ........................................................................................................................................... 177
gb gb
Chapter 46. Pain Management: Acute and Chronic Pain .................................................................................. 181
gb gb gb gb gb gb gb
Chapter 47. Pneumonia ..................................................................................................................................... 185
gb gb
Chapter 48. Sexually Transmitted Diseases and Vaginitis ................................................................................ 187
gb gb gb gb gb gb
Chapter 49. Substance Use Disorders ............................................................................................................... 190
gb gb gb gb
Chapter 50. Tuberculosis ................................................................................................................................... 195
gb gb
Chapter 51. Upper Respiratory Tract Infection, Pharyngitis, Sinusitis, Otitis Media, and Otitis Externa .......... 197
gb gb gb gb gb gb gb gb gb gb gb gb
Chapter 52. Urinary Tract Infections ................................................................................................................ 200
gb gb gb gb
Chapter 53. Women as Patients......................................................................................................................... 203
gb gb gb gb
Chapter 54. Men as Patients .............................................................................................................................. 207
gb gb gb gb
Chapter 55. Pediatric Patients ........................................................................................................................... 209
gb gb gb
Chapter 57. Geriatric Patients ........................................................................................................................... 213
gb gb gb
, Woo 1
Pharmacotherapeutics for APN Prescribers, 6e gb gb gb gb Ch01
Chapter 1. The Role of the Advanced Practice Nurse as Prescriber
gb gb gb gb gb gb gb gb gb gb
MULTIPLE CHOICE gb
1. Nurse practitioner prescriptive authority is regulated by:
gb gb gb gb gb gb
A. The National Council of State Boards of Nursing
gb gb gb gb gb gb gb
B. The U.S. Drug Enforcement Administration
gb gb gb gb
C. The State Board of Nursing for each state
gb gb gb gb gb gb gb
D. The State Board of Pharmacy
gb gb gb gb
ANS: C g b PTS: g b g b 1
2. The benefits to the patient of having an advanced practice registered nurse (APRN) prescriber i
gb gb gb gb gb gb gb gb gb gb gb gb gb gb
nclude:
A. Nurses know more about pharmacology than other prescribers because they take it
gb gb gb gb gb gb gb gb gb gb gb gb
both in their basic nursing program and in their APRN program.
gb gb gb gb gb gb gb gb gb gb
B. Nurses care for the patient from a holistic approach and include the patient in
gb gb gb gb gb gb gb gb gb gb gb gb gb gb
decision-making regarding their care. gb gb gb
C. APRNs are less likely to prescribe narcotics and other controlled substances.
gb gb gb gb gb gb gb gb gb gb
D. APRNs are able to prescribe independently in all states, whereas a physician’s
gb gb gb gb gb gb gb gb gb gb gb gb
assistant needs to have a physician supervising their practice.
gb gb gb gb gb gb gb gb
ANS: B g b PTS: g b g b 1
3. Clinical judgment in prescribing includes:
gb gb gb gb
A. Factoring in the cost to the patient of the medication prescribed
gb gb gb gb gb gb gb gb gb gb
B. Always prescribing the newest medication available for the disease process
gb gb gb gb gb gb gb gb gb
C. Handing out drug samples to poor patients gb gb gb gb gb gb
D. Prescribing all generic medications to cut costs gb gb gb gb gb gb
ANS: A g b PTS: g b g b 1
4. The process for choosing an effective drug for a disorder includes:
gb gb gb gb gb gb gb gb gb gb
A. Asking the patient what drug they think would work best for them
gb gb gb gb gb gb gb gb gb gb gb
B. Consulting nationally recognized guidelines for disease management
gb gb gb gb gb gb
C. Prescribing medications that are available as samples before writing a prescription
gb gb gb gb gb gb gb gb gb gb
D. Following U.S. Drug Enforcement Administration guidelines for prescribing
gb gb gb gb gb gb gb
ANS: B g b PTS: g b g b 1
5. Nonintentional nonadherence of drug therapy may occur due to: gb gb gb gb gb gb gb gb
A. Belief that medication does not work
gb gb gb gb gb
B. Adverse drug reactions gb gb
C. Chronic conditions that require daily therapygb gb gb gb gb
D. Forgetfulness or distraction gb gb
ANS: D g b PTS: g b g b 1
